Nektar Therapeutics Community Page | What other sites are saying about Nektar Therapeutics

Nektar Therapeutics

(NQ: NKTR)

9.730 USD -0.040 (-0.41%)

Official Closing Price / Updated: 5:20 PM EDT, May 21, 2013 / Add to My Watchlist

(NKTR) Community Analysis from

READ MORE (NKTR)

Bulls REASONS TO BUY

View all Bulls Reasons

Bears REASONS TO SELL

View all Bears Reasons

May 21, 2013

Hapoalim Securities Raises Target On Nektar Therapeutics (NKTR)

(Benzinga, 11/5/10)

Hapoalim Securities raised its price target on Nektar Therapeutics (NASDAQ: NKTR) to $19 from $16. It is reiterating its Buy rating on shares. In a note to clients, Hapoalim writes, "After the impressive Phase II ovarian and breast...(read more)

Top 4 Stocks In The Drug Delivery Industry With The Highest Cash (HSP, ELN, NKTR, ALKS)

(Benzinga, 11/2/10)

Below are the top drug delivery stocks on the NYSE and the NASDAQ in terms of cash. Hospira Inc (NYSE: HSP) had $1.15 billion in total cash for the latest quarter. HSP's total debt stood at $2.24 billion in the same period. Elan...(read more)

(NKTR) Nektar Therapeutics Announces Preliminary Data

(Stock Blog Hub, 1/13/10)

Recently, Nektar Therapeutics (NKTR) announced preliminary results from the first stage of phase II study of its experimental ovarian cancer drug, NKTR-102. It has been...(read more)

View all posts about Nektar Therapeutics (NKTR)

Nektar Therapeutics (NKTR) Company Overview

There is no analysis for NKTR yet. But you can go to Wikinvest to help create one!

Stock Market XML and JSON Data API provided by FinancialContent Services, Inc.
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates